Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous.
Lupus
PROMIS
patient-reported outcomes
Journal
Lupus
ISSN: 1477-0962
Titre abrégé: Lupus
Pays: England
ID NLM: 9204265
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
pubmed:
20
11
2021
medline:
24
2
2022
entrez:
19
11
2021
Statut:
ppublish
Résumé
The evaluation of Patient Reported Outcomes Measurement Information System (PROMIS) computerized adaptive test (CAT) in adults with systemic lupus erythematous (SLE) is an emerging field of research. We aimed to examine the test-retest reliability and construct validity of the PROMIS CAT in a Canadian cohort of patients with SLE. Two hundred twenty-seven patients completed 14 domains of PROMIS CAT and seven legacy instruments during their clinical visits. Test-retest reliability of PROMIS was evaluated 7-10 days from baseline using intraclass correlation coefficient (ICC (2; 1)). The construct validity of the PROMIS CAT domains was evaluated against the commonly used legacy instruments, and also in comparison to disease activity and disease damage using Spearman correlations. A multitrait-multimethod matrix (MMM) approach was used to further assess construct validity comparing selected 10 domains of PROMIS and SF-36 domains. Moderate to excellent reliability was found for all domains (ICC [2;1] ranging from lowest, 0.66 for Sleep Disturbance and highest, 0.93 for the Mobility domain). Comparing seven legacy instruments with 14 domains of PROMIS CAT, moderate to strong correlations (0.51-0.91) were identified. The average time to complete all PROMIS CAT domains was 11.7 min. The MMM further established construct validity by showing moderate to strong correlations (0.55-0.87) between select PROMIS and SF-36 domains; the average correlations from similar traits (convergent validity) were significantly greater than the average correlations from different traits. These results provide evidence on the reliability and validity of PROMIS CAT in SLE in a Canadian cohort.
Sections du résumé
BACKGROUND
BACKGROUND
The evaluation of Patient Reported Outcomes Measurement Information System (PROMIS) computerized adaptive test (CAT) in adults with systemic lupus erythematous (SLE) is an emerging field of research. We aimed to examine the test-retest reliability and construct validity of the PROMIS CAT in a Canadian cohort of patients with SLE.
METHODS
METHODS
Two hundred twenty-seven patients completed 14 domains of PROMIS CAT and seven legacy instruments during their clinical visits. Test-retest reliability of PROMIS was evaluated 7-10 days from baseline using intraclass correlation coefficient (ICC (2; 1)). The construct validity of the PROMIS CAT domains was evaluated against the commonly used legacy instruments, and also in comparison to disease activity and disease damage using Spearman correlations. A multitrait-multimethod matrix (MMM) approach was used to further assess construct validity comparing selected 10 domains of PROMIS and SF-36 domains.
RESULTS
RESULTS
Moderate to excellent reliability was found for all domains (ICC [2;1] ranging from lowest, 0.66 for Sleep Disturbance and highest, 0.93 for the Mobility domain). Comparing seven legacy instruments with 14 domains of PROMIS CAT, moderate to strong correlations (0.51-0.91) were identified. The average time to complete all PROMIS CAT domains was 11.7 min. The MMM further established construct validity by showing moderate to strong correlations (0.55-0.87) between select PROMIS and SF-36 domains; the average correlations from similar traits (convergent validity) were significantly greater than the average correlations from different traits.
CONCLUSIONS
CONCLUSIONS
These results provide evidence on the reliability and validity of PROMIS CAT in SLE in a Canadian cohort.
Identifiants
pubmed: 34797991
doi: 10.1177/09612033211051275
pmc: PMC8649426
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2102-2113Références
Neuropsychiatr Dis Treat. 2018 Oct 29;14:2861-2877
pubmed: 30464471
J Rheumatol. 2006 Dec;33(12):2453-7
pubmed: 17143980
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Med Care. 1993 Mar;31(3):247-63
pubmed: 8450681
J Rheumatol. 2014 Jan;41(1):153-8
pubmed: 24241485
Arthritis Rheum. 2006 Jun 15;55(3):434-41
pubmed: 16739211
J Orthop Trauma. 2014 Aug;28(8):439-43
pubmed: 24378399
Psychol Bull. 1959 Mar;56(2):81-105
pubmed: 13634291
Clin Neuropsychol. 2004 Feb;18(1):132-47
pubmed: 15595365
Arthritis Rheum. 2009 Sep 15;61(9):1179-86
pubmed: 19714612
Lupus Sci Med. 2020 Jun;7(1):
pubmed: 32591423
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S413-9
pubmed: 22588761
Br J Math Stat Psychol. 2011 Feb;64(Pt 1):38-52
pubmed: 21506944
J Rheumatol. 2011 Apr;38(4):672-9
pubmed: 21239746
Rheumatology (Oxford). 2020 Nov 1;59(11):3211-3220
pubmed: 32221602
Med Care. 1994 Jan;32(1):40-66
pubmed: 8277801
J Ment Health Policy Econ. 2011 Dec;14(4):201-8
pubmed: 22345362
Semin Arthritis Rheum. 2019 Oct;49(2):260-266
pubmed: 30940467
Arthritis Care Res (Hoboken). 2017 Jan;69(1):133-142
pubmed: 27111350
Arthritis Care Res (Hoboken). 2018 Jan;70(1):104-113
pubmed: 28371529
Am J Sports Med. 2014 Dec;42(12):2906-16
pubmed: 25288625
Support Care Cancer. 2015 May;23(5):1355-64
pubmed: 25351456
J Rheumatol. 2017 Jul;44(7):1024-1031
pubmed: 28412708
J Rheumatol. 2020 Aug 1;47(8):1182-1188
pubmed: 31371654
J Clin Epidemiol. 2010 Nov;63(11):1179-94
pubmed: 20685078
Rheumatology (Oxford). 2013 Apr;52(4):684-96
pubmed: 23264550
Health Qual Life Outcomes. 2014 Jul 22;12:116
pubmed: 25048687
Lupus. 2011 Jan;20(1):35-43
pubmed: 21233148
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Lupus. 2010 Jan;19(1):49-51
pubmed: 19910390
Arthritis Care Res (Hoboken). 2018 Jan;70(1):125-133
pubmed: 28320078
Arthritis Rheum. 1982 Nov;25(11):1271-7
pubmed: 7138600
J Rheumatol. 2000 Feb;27(2):373-6
pubmed: 10685799
Lupus Sci Med. 2018 Aug 21;5(1):e000279
pubmed: 30167315
Arthritis Rheumatol. 2014 Oct;66(10):2900-8
pubmed: 24964773
PLoS One. 2015 Sep 17;10(9):e0138543
pubmed: 26379233
J Rheumatol. 2018 Mar;45(3):397-404
pubmed: 29419473
Qual Life Res. 2016 Aug;25(8):2109-16
pubmed: 26914103
Ann Rheum Dis. 2015 Jan;74(1):104-7
pubmed: 24095937